Englewood Lab, Inc. (KOSDAQ:950140)
South Korea · Delayed Price · Currency is KRW 9,020.00
-100.00 (-1.10%)
At close: Jun 2, 2026
Englewood Lab Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 223,999 | 216,790 | 182,220 | 206,784 | 151,509 | 160,816 |
Other Revenue | - | - | - | - | -0 | - |
| 223,999 | 216,790 | 182,220 | 206,784 | 151,509 | 160,816 | |
Revenue Growth (YoY) | 30.74% | 18.97% | -11.88% | 36.48% | -5.79% | 17.24% |
Cost of Revenue | 162,686 | 156,892 | 143,781 | 159,130 | 125,804 | 126,615 |
Gross Profit | 61,313 | 59,899 | 38,440 | 47,654 | 25,705 | 34,202 |
Selling, General & Admin | 18,874 | 18,492 | 15,036 | 16,159 | 12,389 | 13,223 |
Research & Development | 3,090 | 3,133 | 2,808 | 2,218 | 2,433 | 2,437 |
Amortization of Goodwill & Intangibles | 22.71 | 16.82 | 18.1 | 20.63 | 48.13 | 49.16 |
Other Operating Expenses | 526.66 | 519 | 410.53 | - | - | - |
Operating Expenses | 22,915 | 22,531 | 19,645 | 18,799 | 15,823 | 17,297 |
Operating Income | 38,398 | 37,368 | 18,795 | 28,855 | 9,882 | 16,905 |
Interest Expense | -1,094 | -1,157 | -906.85 | -698.93 | -977.36 | -741.1 |
Interest & Investment Income | 783.97 | 750.36 | 599.38 | 218.05 | 12.11 | 7.76 |
Currency Exchange Gain (Loss) | 3,666 | -372.52 | 7,229 | 42.38 | 545.21 | 1,028 |
Other Non Operating Income (Expenses) | -832.72 | -877.39 | 17.6 | -19.2 | -234.14 | -32.29 |
EBT Excluding Unusual Items | 40,922 | 35,712 | 25,734 | 28,397 | 9,227 | 17,167 |
Gain (Loss) on Sale of Investments | -1.51 | 0.4 | - | - | - | - |
Gain (Loss) on Sale of Assets | 51.13 | 33.92 | 9.9 | 317.98 | -650.31 | -1,701 |
Asset Writedown | - | - | - | - | -224.1 | -367.97 |
Pretax Income | 40,971 | 35,746 | 25,744 | 28,715 | 8,353 | 15,098 |
Income Tax Expense | 12,338 | 10,932 | 6,116 | 7,973 | 1,088 | 100.74 |
Net Income | 28,633 | 24,815 | 19,628 | 20,742 | 7,265 | 14,997 |
Net Income to Common | 28,633 | 24,815 | 19,628 | 20,742 | 7,265 | 14,997 |
Net Income Growth | 77.28% | 26.42% | -5.37% | 185.50% | -51.55% | 386.63% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Change (YoY) | -1.62% | -0.84% | 0.60% | - | - | - |
EPS (Basic) | 1448.58 | 1252.00 | 982.00 | 1044.02 | 365.69 | 754.85 |
EPS (Diluted) | 1448.58 | 1252.00 | 982.00 | 1044.02 | 365.69 | 754.85 |
EPS Growth | 80.20% | 27.50% | -5.94% | 185.50% | -51.55% | 386.63% |
Free Cash Flow | 14,590 | 15,684 | 8,549 | 18,060 | 5,462 | -9,232 |
Free Cash Flow Per Share | 738.13 | 791.35 | 427.74 | 908.99 | 274.94 | -464.68 |
Gross Margin | 27.37% | 27.63% | 21.09% | 23.04% | 16.97% | 21.27% |
Operating Margin | 17.14% | 17.24% | 10.32% | 13.95% | 6.52% | 10.51% |
Profit Margin | 12.78% | 11.45% | 10.77% | 10.03% | 4.79% | 9.33% |
Free Cash Flow Margin | 6.51% | 7.23% | 4.69% | 8.73% | 3.60% | -5.74% |
EBITDA | 43,766 | 42,601 | 23,912 | 33,249 | 14,230 | 21,209 |
EBITDA Margin | 19.54% | 19.65% | 13.12% | 16.08% | 9.39% | 13.19% |
D&A For EBITDA | 5,367 | 5,233 | 5,116 | 4,394 | 4,349 | 4,304 |
EBIT | 38,398 | 37,368 | 18,795 | 28,855 | 9,882 | 16,905 |
EBIT Margin | 17.14% | 17.24% | 10.32% | 13.95% | 6.52% | 10.51% |
Effective Tax Rate | 30.11% | 30.58% | 23.76% | 27.77% | 13.02% | 0.67% |
Advertising Expenses | - | 186.62 | 175.48 | 116.46 | 54.36 | 12.05 |